Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Aminocaproic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLG known ✓ | P00747 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gamma-Aminobutyric Acid SCHEMBL2897912 | 0.95 | KMT2A (0.41) | ALDH1A1MEN1PLGLMNATHRB | |
| SCHEMBL2714415 | 0.78 | SMN1; SMN2 (0.50) | ALDH1A1MEN1PLGLMNARECQL | |
| SCHEMBL24534659 | 0.75 | SMN1; SMN2 (0.47) | ALDH1A1MEN1PLGLMNARECQL | |
| Gamma-Aminobutyric Acid SCHEMBL5795191 | 0.71 | HDAC3 (0.41) | ALDH1A1MEN1PLGLMNATHRB | |
| Naphthalene SCHEMBL6898872 | 0.70 | LMNA (0.68) | ALDH1A1MEN1PLGLMNATHRB | |
| Sebacic Acid SCHEMBL27729682 | 0.68 | HDAC3 (0.61) | ALDH1A1MEN1PLGLMNATHRB | |
| Biphenyl SCHEMBL3175348 | 0.68 | HDAC3 (0.65) | ALDH1A1LMNASLC6A3NFKB1NPSR1 | |
| Biphenyl SCHEMBL7642659 | 0.68 | HDAC3 (0.65) | ALDH1A1LMNASLC6A3NFKB1NPSR1 | |
| Sebacic Acid SCHEMBL3165598 | 0.68 | HDAC3 (0.65) | ALDH1A1LMNASLC6A3NFKB1NPSR1 | |
| Octanedioate SCHEMBL8026045 | 0.68 | HDAC3 (0.65) | ALDH1A1LMNASLC6A3NFKB1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120129710-A1 | METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS | MEDIMMUNE LIMITED (GB) | 2012-05-24 | — | — | US | disclosed |
| EP-1754787-B1 | Methods for producing members of specific binding pairs | MEDIMMUNE LTD (GB) | 2012-01-25 | — | — | EP | disclosed |
| US-20100317540-A1 | METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS | MEDICAL RESEARCH COUNCIL (GB) | 2010-12-16 | — | — | US | disclosed |
| US-7732377-B2 | Methods for producing members of specific binding pairs | MEDICAL RESEARCH COUNCIL (GB) | 2010-06-08 | — | — | US | disclosed |
| US-20100136660-A1 | METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS | MCCAFFERTY JOHN | 2010-06-03 | — | — | US | disclosed |
| US-7723270-B1 | Methods for producing members of specific binding pairs | MEDICAL RESEARCH COUNCIL (GB) | 2010-05-25 | — | — | US | disclosed |
| US-7662557-B2 | comprises a filamentous bacteriophage particle displaying on its surface a binding molecule which has a binding domain able to bind target epitope or antigen; genetic engineering | MEDICAL RESEARCH COUNCIL (GB) | 2010-02-16 | — | — | US | disclosed |
| US-7635666-B1 | Methods for producing members of specific binding pairs | MEDICAL RESEARCH COUNCIL (GB) | 2009-12-22 | — | — | US | disclosed |
| US-20090155810-A1 | METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS | MEDICAL RESEARCH COUNCIL (GB) | 2009-06-18 | — | — | US | disclosed |
| EP-1847605-A2 | Methods for producing members of specific binding pairs | Cambridge Antibody Technology Limited (GB) | 2007-10-24 | — | — | EP | disclosed |
| EP-0589877-B2 | METHODS FOR PRODUCING FUNCTIONAL, SINGLE-CHAIN Fv ANTIBODY FRAGMENTS ON THE SURFACE OF BACTERIOPHAGE PARTICLES | CAMBRIDGE ANTIBODY TECH (GB) | 2005-10-26 | — | — | EP | disclosed |
| US-6916605-B1 | Methods for producing members of specific binding pairs | MEDICAL RESEARCH COUNCIL (GB) | 2005-07-12 | — | — | US | disclosed |
| US-6806079-B1 | BACTERIOPHAGES; USED TO PRODUCE MONOCLONAL ANTIBODIES HAVING A SPECIFICITY AGAINST A PARTICULAR EPITOPE; IMMUNIZATION; SCREENING | MEDICAL RESEARCH COUNCIL (GB) | 2004-10-19 | — | — | US | disclosed |
| US-20040157214-A1 | Methods for producing members of specific binding pairs | CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED | 2004-08-12 | — | — | US | disclosed |
| US-20040157215-A1 | Methods for producing members of specific binding pairs | CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED | 2004-08-12 | — | — | US | disclosed |
| US-6172197-B1 | LIBRARY OF FILAMENTOUS BACTERIOPHAGE PARTICLES DISPLAYING ON THEIR SURFACE FUSION PROTEINS OF PREFERENTIAL BINDING PROTEINS; FOR USE AS EFFICIENT GENETIC ENGINEERING DIAGNOSTIC TOOLS | MEDICAL RESEARCH COUNCIL (GB) | 2001-01-09 | — | — | US | disclosed |
| US-5969108-A | Methods for producing members of specific binding pairs | MEDICAL RESEARCH COUNCIL (GB) | 1999-10-19 | — | — | US | disclosed |
| EP-0844306-A1 | Methods of producing members of specific binding pairs | Cambridge Antibody Technology Limited (GB) | 1998-05-27 | — | — | EP | disclosed |
| EP-0589877-B1 | METHODS FOR PRODUCING FUNCTIONAL, SINGLE-CHAIN Fv ANTIBODY FRAGMENTS ON THE SURFACE OF BACTERIOPHAGE PARTICLES | CAMBRIDGE ANTIBODY TECH (GB) | 1996-11-13 | — | — | EP | disclosed |
| WO-1992001047-A1 | METHODS FOR PRODUCING MEMBERS OF SPECIFIC BINDING PAIRS | CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED (GB) | 1992-01-23 | — | — | WO | disclosed |